DocGo Inc.
NASDAQ:DCGOMedical - Care Facilities
-$0.02 today
- Market cap
- $70.14M
- Beta
- 1.00
- P/E (TTM)
- -0.3
- EPS (TTM)
- -$1.90
Volume 1.64M
Average 0.87M
DCGO Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
DocGo Inc.NASDAQ: DCGO
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow turns positive
Q1 FY2026 investing cash flow was $1.66T, compared with -$5.73M a year earlier. Trailing-twelve-month investing cash flow was $1.66T. Over 3 fiscal years it compounded at +0.5% a year.
Context
- Investing cash flow amounted to 12.1% of revenue in FY2025, up 10.4 pp from a year earlier.
- Investing cash flow grew in size in 1 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly investing cash flow holds near $1.66T or moves back toward the trailing-twelve-month quarterly average of $414.77B.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (39.08M) USD
- Year-over-year change
- -259.5%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (39.08M) | -259.5% |
| FY2024 | 2024-12-31 | (10.87M) | +63.6% |
| FY2023 | 2023-12-31 | (29.88M) | +22.3% |
| FY2022 | 2022-12-31 | (38.45M) | -347.6% |
| FY2021 | 2021-12-31 | (8.59M) | — |
Investing Cash Flow vs competitors
How DCGO compares with its peers on the latest reported figures
- DCGO's LTM Mar 2026 investing cash flow of $1.66T is the largest of the 9 companies compared; the peer median is $7M.
- Its year-over-year change of +11130739.1% is the highest of 8, against a peer median of -88.7%.
- Investing cash flow amounts to 549888.2% of revenue for DCGO, versus a peer median of 38.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.66T | +11130739.1% | +0.5% | 549888.2% | |
| LTM Mar 2026 | $78.68M | -158.5% | — | 50.1% | |
| LTM Mar 2026 | $49.01M | -224.0% | -17.2% | 688.1% | |
| LTM Mar 2026 | $42.56M | +93.4% | +166.2% | 40530.5% | |
| LTM Mar 2026 | $11.95M | +1166.3% | — | — | |
| LTM Mar 2026 | $3.73M | -88.7% | — | 5.2% | |
| LTM Mar 2026 | $2.05M | — | +30.4% | 25.8% | |
| LTM Mar 2026 | $1.17M | +209.0% | +51.4% | — | |
| LTM Mar 2026 | $228K | -100.2% | -13.2% | 1.4% | |
| Peer median (excluding DCGO) | $7M | -88.7% | +30.4% | 38.0% | |
Competitors are the stored peer set for DCGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 19.18M | 30.74M | 6.86M | 19.99M | (196.37M) |
| Depreciation & Amortization | 7.07M | 10.57M | 16.43M | 15.88M | 15.66M |
| Deferred Income Tax | (630.38K) | (9.96M) | (1.98M) | 3.47M | 7.75M |
| Stock-Based Compensation | 1.38M | 8.05M | 20.97M | 13.63M | 17.44M |
| Change in Working Capital | (28.8M) | (13.18M) | (113.12M) | 19.52M | 81.66M |
| Accounts Receivables | (58M) | (8.42M) | (160.52M) | 41.27M | 112.5M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 11.88M | 3.64M | (1.78M) | 8.56M | (17.64M) |
| Other Working Capital | 17.31M | (8.4M) | 49.18M | (30.32M) | (13.19M) |
| Other Non-Cash Items | (142.67K) | 2.64M | 6.62M | (2.16M) | 108.31M |
| Operating Cash Flow | (1.95M) | 28.87M | (64.22M) | 70.34M | 34.45M |
| Capital Expenditures | (6.66M) | (5.5M) | (10.13M) | (5.84M) | (7.43M) |
| Acquisitions (Net) | (1.96M) | (32.95M) | (19.46M) | (310.45K) | (16.4M) |
| Purchases of Investments | (655.88K) | 0 | 0 | (5M) | 0 |
| Sales of Investments | 655.88K | 0 | 0 | 0 | 13.16M |
| Other Investing Activities | (1.82M) | (2.3M) | (2.84M) | (1.73M) | (31.3M) |
| Investing Cash Flow | (8.59M) | (38.45M) | (29.88M) | (10.87M) | (39.08M) |
| Debt Repayment | (2.82M) | (3.94M) | 20.7M | 613.55K | (35.17M) |
| Common Stock Issued | 178.1M | 0 | 1.58M | 0 | 0 |
| Common Stock Repurchased | (479.33K) | (3.73M) | 0 | (13.76M) | (10.83M) |
| Dividends Paid | 0 | 0 | 0 | (1.29T) | 0 |
| Other Financing Activities | (19.6M) | 1.49M | (21.17M) | 1.29T | (4.82M) |
| Financing Cash Flow | 155.21M | (6.18M) | 1.12M | (24.15M) | (50.82M) |
| Effect of Forex Changes | (21.41K) | 761.23K | 1.09M | (190.64K) | 595.8K |
| Net Change in Cash | 144.65M | (15M) | (91.89M) | 35.12M | (54.85M) |
| Free Cash Flow | (8.6M) | 23.37M | (74.35M) | 64.5M | 27.02M |
DocGo Inc.
NASDAQ:DCGO
Intrinsic Alpha fair value
Locked
Current Price
$0.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.